{"transactions":[{"id":758288,"issuer":{"id":4958,"kind":"organization","name":"Immix Biopharma, Inc."},"owners":[{"id":43080,"kind":"person","name":"Ng Carey","position":1,"cik":"0001889522","reported_name":"Ng Carey","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-29T21:05:25.000Z","date":"2026-05-22","kind":"grant","planned":false,"acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option will vest in substantially equal monthly installments over the 12 months following the date of grant (or, in the event the 2027 Annual Meeting occurs prior to the first anniversary of the date of grant, any remaining unvested portion of the stock option will vest on the date of such 2027 Annual Meeting), subject to the Reporting Person's continued service on the Issuer's Board through the applicable vesting date."}],"balance_after":12500,"derivative":{"exercise_price":8.78,"expiration_date":"2036-05-22","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001493152-26-026430","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1873835/000149315226026430/ownership.xml","form_type":"4"}},{"id":758287,"issuer":{"id":4958,"kind":"organization","name":"Immix Biopharma, Inc."},"owners":[{"id":43080,"kind":"person","name":"Ng Carey","position":1,"cik":"0001889522","reported_name":"Ng Carey","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-29T21:05:25.000Z","date":"2026-05-22","kind":"grant","planned":false,"acquired":true,"shares":6250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person was granted 6,250 restricted stock units (\"RSUs\") pursuant to the Issuer's 2021 Equity Incentive Plan, which RSUs will vest in full on the earlier of (i) the one-year anniversary of the date of grant, and (ii) the date that the Issuer's 2027 annual meeting of stockholders (the \"2027 Annual Meeting\") is held, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":26250,"source":{"system":"sec-edgar","filing":"0001493152-26-026430","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1873835/000149315226026430/ownership.xml","form_type":"4"}},{"id":1103383,"issuer":{"id":4958,"kind":"organization","name":"Immix Biopharma, Inc."},"owners":[{"id":43080,"kind":"person","name":"Ng Carey","position":1,"cik":"0001889522","reported_name":"Ng Carey","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-23T20:57:40.000Z","date":"2025-06-20","kind":"grant","planned":false,"acquired":true,"shares":33000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Stock Option will vest in twelve (12) equal monthly installments following the date of grant, subject to the Reporting Person's continued service on the Board of Directors."}],"balance_after":33000,"derivative":{"exercise_price":2.24,"expiration_date":"2035-06-20","underlying":"Common Stock","underlying_shares":33000},"source":{"system":"sec-edgar","filing":"0001641172-25-016115","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1873835/000164117225016115/ownership.xml","form_type":"4"}},{"id":1428628,"issuer":{"id":4958,"kind":"organization","name":"Immix Biopharma, Inc."},"owners":[{"id":43080,"kind":"person","name":"Ng Carey","position":1,"cik":"0001889522","reported_name":"Ng Carey","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-20T00:45:04.000Z","date":"2024-08-16","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":1.86,"value":18600.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $1.84 to $1.915, inclusive. The price reported above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":20000,"source":{"system":"sec-edgar","filing":"0001493152-24-033205","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1873835/000149315224033205/ownership.xml","form_type":"4"}},{"id":1471594,"issuer":{"id":4958,"kind":"organization","name":"Immix Biopharma, Inc."},"owners":[{"id":43080,"kind":"person","name":"Ng Carey","position":1,"cik":"0001889522","reported_name":"Ng Carey","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-21T21:45:11.000Z","date":"2024-06-11","kind":"grant","planned":false,"acquired":true,"shares":33000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Stock Option will vest in twelve (12) equal monthly installments following the date of grant, subject to the Reporting Person's continued service on the Board of Directors."}],"balance_after":33000,"derivative":{"exercise_price":2.04,"expiration_date":"2034-06-11","underlying":"Common Stock","underlying_shares":33000},"source":{"system":"sec-edgar","filing":"0001493152-24-024827","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1873835/000149315224024827/ownership.xml","form_type":"4"}},{"id":1508347,"issuer":{"id":4958,"kind":"organization","name":"Immix Biopharma, Inc."},"owners":[{"id":43080,"kind":"person","name":"Ng Carey","position":1,"cik":"0001889522","reported_name":"Ng Carey","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-20T21:25:38.000Z","date":"2024-05-15","kind":"grant","planned":false,"acquired":true,"shares":25512,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Issued to replace prior awards held by the Reporting Person in Nexcella, Inc., in contemplation of the merger of Nexcella, Inc. and the Issuer, which became effective on May 20, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Stock Option will vest in thirteen (13) equal monthly installments following the date of grant, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":25512,"derivative":{"exercise_price":2.47,"expiration_date":"2033-05-26","underlying":"Common Stock","underlying_shares":25512},"source":{"system":"sec-edgar","filing":"0001493152-24-020775","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1873835/000149315224020775/ownership.xml","form_type":"4"}},{"id":1508346,"issuer":{"id":4958,"kind":"organization","name":"Immix Biopharma, Inc."},"owners":[{"id":43080,"kind":"person","name":"Ng Carey","position":1,"cik":"0001889522","reported_name":"Ng Carey","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-20T21:25:38.000Z","date":"2024-05-15","kind":"grant","planned":false,"acquired":true,"shares":21587,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Issued to replace prior awards held by the Reporting Person in Nexcella, Inc., in contemplation of the merger of Nexcella, Inc. and the Issuer, which became effective on May 20, 2024."}],"balance_after":21587,"derivative":{"exercise_price":2.47,"exercise_date":"2024-05-15","expiration_date":"2033-05-26","underlying":"Common Stock","underlying_shares":21587},"source":{"system":"sec-edgar","filing":"0001493152-24-020775","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1873835/000149315224020775/ownership.xml","form_type":"4"}},{"id":1779698,"issuer":{"id":4958,"kind":"organization","name":"Immix Biopharma, Inc."},"owners":[{"id":43080,"kind":"person","name":"Ng Carey","position":1,"cik":"0001889522","reported_name":"Ng Carey","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-09-15T22:27:44.000Z","date":"2023-09-14","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":2.576,"value":25760.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $2.51 to $2.60, inclusive. The price reported above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001493152-23-032829","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1873835/000149315223032829/ownership.xml","form_type":"4"}},{"id":1808094,"issuer":{"id":4958,"kind":"organization","name":"Immix Biopharma, Inc."},"owners":[{"id":43080,"kind":"person","name":"Ng Carey","position":1,"cik":"0001889522","reported_name":"Ng Carey","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2023-08-14T20:15:38.000Z","date":"2023-08-11","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options vest monthly over 12 months from the date of grant."}],"balance_after":20000,"derivative":{"exercise_price":1.86,"expiration_date":"2033-08-11","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001493152-23-028472","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1873835/000149315223028472/ownership.xml","form_type":"4"}},{"id":2206110,"issuer":{"id":4958,"kind":"organization","name":"Immix Biopharma, Inc."},"owners":[{"id":43080,"kind":"person","name":"Ng Carey","position":1,"cik":"0001889522","reported_name":"Ng Carey","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2022-07-18T10:08:00.000Z","date":"2022-07-14","kind":"grant","acquired":true,"shares":16000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options vest monthly over 12 months from date of grant."}],"balance_after":16000,"derivative":{"exercise_price":2.64,"expiration_date":"2032-07-14","underlying":"Common Stock","underlying_shares":16000},"source":{"system":"sec-edgar","filing":"0001493152-22-019505","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1873835/000149315222019505/ownership.xml","form_type":"4"}},{"id":2463456,"issuer":{"id":4958,"kind":"organization","name":"Immix Biopharma, Inc."},"owners":[{"id":43080,"kind":"person","name":"Ng Carey","position":1,"cik":"0001889522","reported_name":"Ng Carey","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Convertible Note","published_at":"2021-12-20T21:15:13.000Z","date":"2021-12-20","kind":"exercise","acquired":false,"price":0,"reported_value":750000,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On October 30, 2019, the Registrant issued Mesa Verde Venture Partners III, LP a note in the amount of $750,000 which is payable upon request of the majority holders of like tenure notes on or after October 30, 2021. Pursuant to the terms of the note, because the Registrant sold equity securities in its initial public offering resulting in proceeds of at least $10 million, the note automatically converted into shares of the Registrant's common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On October 30, 2019, the Registrant issued Mesa Verde Venture Partners III, LP a note in the amount of $750,000 which is payable upon request of the majority holders of like tenure notes on or after October 30, 2021. Pursuant to the terms of the note, because the Registrant sold equity securities in its initial public offering resulting in proceeds of at least $10 million, the note automatically converted into shares of the Registrant's common stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Carey Ng is the Managing Director of Mesa Verde Venture Partners III, LP and in such capacity has the right to vote and dispose of the securities held by such entity."}],"balance_after":0,"derivative":{"exercise_price":0.85,"underlying":"Common stock","underlying_shares":1000221},"source":{"system":"sec-edgar","filing":"0001493152-21-032034","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1873835/000149315221032034/ownership.xml","form_type":"4"}},{"id":2463455,"issuer":{"id":4958,"kind":"organization","name":"Immix Biopharma, Inc."},"owners":[{"id":43080,"kind":"person","name":"Ng Carey","position":1,"cik":"0001889522","reported_name":"Ng Carey","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-12-20T21:15:13.000Z","date":"2021-12-20","kind":"purchase","acquired":true,"shares":25000,"price":5,"value":125000.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Carey Ng is the Managing Director of Mesa Verde Venture Partners III, LP and in such capacity has the right to vote and dispose of the securities held by such entity."}],"balance_after":1025221,"source":{"system":"sec-edgar","filing":"0001493152-21-032034","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1873835/000149315221032034/ownership.xml","form_type":"4"}},{"id":2463454,"issuer":{"id":4958,"kind":"organization","name":"Immix Biopharma, Inc."},"owners":[{"id":43080,"kind":"person","name":"Ng Carey","position":1,"cik":"0001889522","reported_name":"Ng Carey","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-12-20T21:15:13.000Z","date":"2021-12-20","kind":"exercise","acquired":true,"shares":1000221,"price":0.85,"value":850187.85,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Carey Ng is the Managing Director of Mesa Verde Venture Partners III, LP and in such capacity has the right to vote and dispose of the securities held by such entity."}],"balance_after":1000221,"source":{"system":"sec-edgar","filing":"0001493152-21-032034","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1873835/000149315221032034/ownership.xml","form_type":"4"}}]}